These Analysts Boost Their Forecasts On Dentsply Sirona Following Q4 Earnings

Dentsply Sirona Inc (NASDAQ:XRAY) reported mixed results for the fourth quarter after the closing bell on Thursday.

The company posted quarterly earnings of 27 cents per share which missed the analyst consensus estimate of 28 cents per share. The company reported quarterly sales of $961.000 million which beat the analyst consensus estimate of $927.081 million.

Dentsply Sirona said it sees FY2026 adjusted EPS of $1.40-$1.50, versus market estimates of $1.50. The company sees sales of $3.500 billion-$3.600 billion, versus market expectations of $3.675 billion.

Dentsply Sirona shares fell 2.2% to $14.36 in pre-market trading.

These analysts made changes to their price targets on Dentsply Sirona following earnings announcement.

• Barrington Research analyst Michael Petusky maintained Dentsply Sirona with an Outperform rating and raised the price target from $14 to $17.
• Mizuho analyst Steven Valiquette maintained the stock with a Neutral and raised the price target from $14 to $16.
• On Friday, Baird analyst Jeffrey Johnson maintained Dentsply Sirona with a Neutral and raised the price target from $12 to $14.
• Evercore ISI Group analyst Elizabeth Anderson maintained the stock with an In-Line rating and raised the price target from $12 to $15.
• Wells Fargo analyst Vik Chopra maintained Dentsply Sirona with an Equal-Weight rating and raised the price target from $12 to $13.

Considering buying XRAY stock? Here’s what analysts think:

Photo via Shutterstock